Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

122.99
Delayed Data
As of Sep 22
 +0.24 / +0.20%
Today’s Change
83.69
Today|||52-Week Range
125.32
+35.33%
Year-to-Date
FBT Regular Dividend: FBT began trading ex-dividend on 09/21/17. A $0.00 dividend will be paid to shareholders of record as of 09/22/17.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.

Performance

1 month+7.24% 3 years+10.40%
3 months+4.36% 5 years+20.89%
1 year+19.81% Since inception+17.64%
Data through 09/23/2017

Quote Details

Previous close$122.75
Open day’s range122.38 – 123.18
Net asset value (NAV)122.94 (09/22/2017)
Daily volume45,665
Average volume (3 months)47,542
Data as of 3:59pm ET, 09/22/2017

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+20.89%+17.39%
Expense Gross exp ratio0.56%1.33%
Risk 5 year sharpe ratio0.991.13
Net assets$1.1B$3.1B
Average market cap$11.9B$32.0B
Average P/E--22.7
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
KITE Kite Pharma Inc5.20%
JUNO Juno Therapeutics Inc4.43%
NBIX Neurocrine Biosciences Inc3.83%
ILMN Illumina Inc3.77%
ACAD ACADIA Pharmaceuticals Inc3.73%
GILD Gilead Sciences3.62%
BIIB Biogen3.57%
AGIO Agios Pharmaceuticals Inc3.53%
ALXN Alexion Pharmaceuticals Inc3.44%
CRL Charles River Laboratories International Inc3.43%